Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples